Sign inJoin free

Watch / Small Cap

An unloved company in an unloved sector | Recce Pharmaceuticals pops after positive trial

28 June 202219:45

An unloved company in an unloved sector | Recce Pharmaceuticals pops after positive trial

General information only. ausbiz videos are general information only, produced by Ausbiz TV Pty Ltd, a media business that doesn’t give financial advice. They don’t take into account your objectives, financial situation or needs. Consider whether it’s right for you and read the PDS and TMD before acting on anything you watch.

About this video

Shares of Recce Pharmaceuticals Ltd (RCE) have been going great after positive market updates about its phase one drug trial results. CEO James Graham joined us from Tampa, Florida, to talk about the pharmaceutical company and its products. Graham says the company has seen an encouraging indication of what may be possible when looking into evident efficacy that would come into phase two.

More like this

We value your privacy

We use essential cookies to make the site work. Non-essential cookies help us improve the experience. You can accept or reject non-essential cookies. Privacy policy